Neuroscience Companies in Europe

Ingen.io creates context and surfaces named entities (people, companies, products, etc.) that are not explicitly mentioned but are part of the broader narrative. All entities, stated or implied are represented in a Contextual Graph with information about their relationship type and weight of importance within the text. Products: Contextual API - provides NER and extracts context, Language Detection API, Part Of Speech tagging API

MindProber is a media measurement solution that gives content producers, distributors, and brands the ability to measure the emotional impact their content has on consumers to optimize advertising and content decisions.

Aequicens was founded at the start of 2018 in Geneva, Switzerland. Aequicens takes a scientific approach to artificial intelligence-based analytics. We rigorously test our solutions before making them available. We build new intelligence and support your business through the innovation circle. We also rely on thinking outside the box to find new ways to compress, abstract, and preprocess data to ensure only the pertinent information is used to construct our models. Underneath it all, we are a knowledge company, not only a technology company, we sell understanding. Our philosophy is to use artificial intelligence when it is useful, not just impressive.

ALEVA is 👉THE COMPANY THAT INTRODUCED Directional Deep Brain Stimulation in Neuromodulation treatments and our clinically proven technology has set the industry standard for directional leads* Today we are 👉A SOLID COMPANY that following directSTIM™'s CE marking have started our commercial journey by partnering with the most important neurological clinics in Germany, with the goal to soon reach the most relevant European markets. We understand that if we want to help OUR CUSTOMERS, overcome their challenges, we need to 👉COMBINE SPECIALISATION with the 👉COMMITMENT TO BE RESPONSIVE to the everyday new challenges they experience. This is the attitude you will find in every ALEVA employee and sales representative who will be in contact with you. We are the 👉ONLY EUROPEAN COMPANY that designs, manufactures, and commercialises DBS devices for the treatment of Parkinson’s disease and essential tremor. Our production and R&D headquarters based in Switzerland complies to the highest quality standard for the highest safety of patients worldwide. Our A VISIONARY PROJECT SUSTAINED BY SOLID FOUNDATIONS: 👉a new group of investors that will sustain the completion of OUR PROJECT 👉a reinforced executive team who is complementing the existing successful group to partner with Neurosurgeons and Neurologists in the effective deployment of our Vision. *May 28, 2014 http://doi.org/10.1093/brain/awu102.

We take immersion to innovative heights. Our soft robotic interfaces interact with the skin, combining temperature, pressure and vibration to create a realistic tactile experience while proprietary algorithms mimic how the brain merges touch with vision, sound, proprioception and movement to create and restore lifelike multi-sensory experiences. Our technology creates a sensory experience with lived emotions, truly connecting the body with the digital world. Its uses in our daily lives are limitless.

Metrion Biosciences is a UK-based Contract Research Organization specialising in high quality ion channel screening and drug development expertise. We aim to provide our customers with access to a range of in vitro screening services that includes cardiac safety (hERG, CiPA panel of human cardiac ion channels) and neurotoxicology testing and phenotypic assays on a fee-for-service or collaboration basis. We pride ourselves on being able to provide a flexible and cost effective service with an unparalleled level of expertise. Collectively, our management team have amassed over 80 years of experience in ion channel drug discovery and our clients can access this high level of expertise as part of our dedicated service.

MindMaze is a global leader in digital neuro-therapeutics (DTx) solutions with a mission to accelerate the brain's ability to recover, learn and adapt. With over a decade of work at the intersection of neuroscience, bio-sensing, engineering, mixed reality and artificial intelligence, its healthcare division is addressing some of the most challenging problems in neurology, including stroke, Alzheimer disease and Parkinson disease, by creating the universal platform for brain health and recovery and unique digital therapeutic interventions. MindMaze's pioneering FDA cleared and CE marked neuro-digital therapeutics accelerate patients' recovery from many critical neurological conditions. Founded in 2012 by CEO Dr Tej Tadi, MindMaze is the first Swiss Unicorn with offices in Lausanne, Baltimore, London, Paris and Mumbai.

Neuronoff, Inc. is developing new medical devices utilizing neuromodulation to restore & improve organ activity in the human body.

Drive revenue with our world-class neuromarketing toolbox. - Increase conversions & pre-test visual assets in seconds with 𝗣𝗿𝗲𝗱𝗶𝗰𝘁 𝗔𝗜 - Reveal real emotions & motivations behind your creatives with 𝗘𝘅𝗽𝗹𝗼𝗿𝗲 - Get granular behavioral data & run full-scale studies with 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 Top brands use Neurons to predict customer behavior & improve performance.

Our mission at OVOMIND is to transform the game experience by making emotions a crucial component of interaction. We do this by using smartbands to read players' biosignals, which creates an unmatched enhanced augmented reality gaming experience. Get ready for an unforgettable and thrilling experience as you immerse yourself in a world where emotions and gaming collide.

Bitbrain was founded in 2010 as a spin-off company of a research team from the University of Zaragoza, pioneer in approaching brain-computer interface applications outside laboratory investigation settings. Its DNA holds all knowledge in neurotechnology, biomedical engineering, artificial intelligence and data science accumulated at the university since 1998. Nowadays, the R+D+I bet is still strong, which has converted the company in a world reference for B2B neurotechnology solutions.

Demiurge pioneers high-accuracy MoA-based prediction of clinical trial outcomes. * Posts here are for information only without any warranty of any kind.

At Neurosoft Bioelectronics, we strive at improving the care of patients who suffer from neurological disorders by developing soft implantable electrodes to interface with the nervous system. We have established a unique technology that allows to manufacture extremely compliant neural interfaces that can achieve long-term bio-integration in the body. These devices will improve therapeutic outcomes in patients as well as open up new applications for neural interfaces that were so far impossible.

Amal Therapeutics is a Biotechnology company located in 64 av., de la Roseraie, 1205 Geneva, Switzerland.

Phracta delivers fresh perspectives to complex ecosystem challenges using fractal analysis with Wardley mapping and other sense-making techniques. Phracta models also enable organisations to safely incorporate Generative AI while enhancing trust.